Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Cooper

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 25, 2021
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical ActivityHeleen Demeyer, Divya Mohan, Chris Burtin, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
The European Respiratory Journal|April 4, 2015
A randomised trial of lung sealant versus medical therapy for advanced emphysemaCarolyn E Come, Mordechai R Kramer, Mark T Dransfield, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2020
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in SmokersEleanor M Dunican, Brett M Elicker, Travis Henry, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 25, 2021
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical ActivityHeleen Demeyer, Divya Mohan, Chris Burtin, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
Respiratory Research|July 4, 2025
Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung StudyDaniel E Guzman, Lisa Ruvuna, Claire J Guo, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
The European Respiratory Journal|April 4, 2015
A randomised trial of lung sealant versus medical therapy for advanced emphysemaCarolyn E Come, Mordechai R Kramer, Mark T Dransfield, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
NPJ Biofilms and Microbiomes|February 6, 2021
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohortKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2020
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in SmokersEleanor M Dunican, Brett M Elicker, Travis Henry, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Pageof 26